Literature DB >> 16009131

Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1.

Jason S Carroll1, X Shirley Liu, Alexander S Brodsky, Wei Li, Clifford A Meyer, Anna J Szary, Jerome Eeckhoute, Wenlin Shao, Eli V Hestermann, Timothy R Geistlinger, Edward A Fox, Pamela A Silver, Myles Brown.   

Abstract

Estrogen plays an essential physiologic role in reproduction and a pathologic one in breast cancer. The completion of the human genome has allowed the identification of the expressed regions of protein-coding genes; however, little is known concerning the organization of their cis-regulatory elements. We have mapped the association of the estrogen receptor (ER) with the complete nonrepetitive sequence of human chromosomes 21 and 22 by combining chromatin immunoprecipitation (ChIP) with tiled microarrays. ER binds selectively to a limited number of sites, the majority of which are distant from the transcription start sites of regulated genes. The unbiased sequence interrogation of the genuine chromatin binding sites suggests that direct ER binding requires the presence of Forkhead factor binding in close proximity. Furthermore, knockdown of FoxA1 expression blocks the association of ER with chromatin and estrogen-induced gene expression demonstrating the necessity of FoxA1 in mediating an estrogen response in breast cancer cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16009131     DOI: 10.1016/j.cell.2005.05.008

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  671 in total

Review 1.  FOXA1: master of steroid receptor function in cancer.

Authors:  Michael A Augello; Theresa E Hickey; Karen E Knudsen
Journal:  EMBO J       Date:  2011-09-20       Impact factor: 11.598

2.  Research resource: enhanced genome-wide occupancy of estrogen receptor α by the cochaperone p23 in breast cancer cells.

Authors:  Natalie E Simpson; Jason Gertz; Keren Imberg; Richard M Myers; Michael J Garabedian
Journal:  Mol Endocrinol       Date:  2011-11-10

3.  The forkhead transcription factor FOXK2 promotes AP-1-mediated transcriptional regulation.

Authors:  Zongling Ji; Ian J Donaldson; Jingru Liu; Andrew Hayes; Leo A H Zeef; Andrew D Sharrocks
Journal:  Mol Cell Biol       Date:  2011-11-14       Impact factor: 4.272

4.  Foxa1 and Foxa2 are essential for sexual dimorphism in liver cancer.

Authors:  Zhaoyu Li; Geetu Tuteja; Jonathan Schug; Klaus H Kaestner
Journal:  Cell       Date:  2012-01-20       Impact factor: 41.582

5.  Cancer: Reprogramming clinical outcome.

Authors:  Geneviève Deblois; Vincent Giguère
Journal:  Nature       Date:  2012-01-18       Impact factor: 49.962

Review 6.  Allosteric modulators of steroid hormone receptors: structural dynamics and gene regulation.

Authors:  Raj Kumar; Iain J McEwan
Journal:  Endocr Rev       Date:  2012-03-20       Impact factor: 19.871

7.  A comprehensive view of nuclear receptor cancer cistromes.

Authors:  Qianzi Tang; Yiwen Chen; Clifford Meyer; Tim Geistlinger; Mathieu Lupien; Qian Wang; Tao Liu; Yong Zhang; Myles Brown; Xiaole Shirley Liu
Journal:  Cancer Res       Date:  2011-09-22       Impact factor: 12.701

8.  Retinoic acid receptors recognize the mouse genome through binding elements with diverse spacing and topology.

Authors:  Emmanuel Moutier; Tao Ye; Mohamed-Amin Choukrallah; Sylvia Urban; Judit Osz; Amandine Chatagnon; Laurence Delacroix; Diana Langer; Natacha Rochel; Dino Moras; Gerard Benoit; Irwin Davidson
Journal:  J Biol Chem       Date:  2012-06-01       Impact factor: 5.157

9.  ANCCA, an estrogen-regulated AAA+ ATPase coactivator for ERalpha, is required for coregulator occupancy and chromatin modification.

Authors:  June X Zou; Alexey S Revenko; Li B Li; Abigael T Gemo; Hong-Wu Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-12       Impact factor: 11.205

10.  Naturally extended CT . AG repeats increase H-DNA structures and promoter activity in the smooth muscle myosin light chain kinase gene.

Authors:  Yoo-Jeong Han; Primal de Lanerolle
Journal:  Mol Cell Biol       Date:  2007-11-08       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.